Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials

被引：0

作者：

Chris J Bushe

Nicola C Savill

机构：

[1] Lilly House,Eli Lilly and Company Ltd

来源：

Child and Adolescent Psychiatry and Mental Health | / 7卷

关键词：

ADHD; Suicide-related events; Summary of product characteristics; Systematic review; Atomoxetine; Methylphenidate;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials
Bushe, Chris J.
Savill, Nicola C.
CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH, 2013, 7
[2] A NETWORK META-ANALYSIS OF ATOMOXETINE, METHYLPHENIDATE, LISDEXAMFETAMINE, AND BUPROPION FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS
Locatelli, I
Venisnik, K.
VALUE IN HEALTH, 2016, 19 (07) : A521 - A522
[3] Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
Raveen Hanwella
Madhri Senanayake
Varuni de Silva
BMC Psychiatry, 11
[4] Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
Hanwella, Raveen
Senanayake, Madhri
de Silva, Varuni
BMC PSYCHIATRY, 2011, 11
[5] TREATMENT DISCONTINUATION IN CLINICAL TRIALS OF METHYLPHENIDATE AND ATOMOXETINE FOR ADULTS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL TRIALS.
Castells, X.
Cunill, R.
Riera, M.
Capella, D.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 22 - 22
[6] Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta-analysis
Patra, Suravi
Nebhinani, Naresh
Viswanathan, Anand
Kirubakaran, Richard
AUTISM RESEARCH, 2019, 12 (04) : 542 - 552
[7] Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials
Liu, Qiang
Zhang, Hong
Fang, Qingqing
Qin, Lili
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2017, 39 (09) : 854 - 865
[8] Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in children and adolescents with attention deficit hyperactivity disorder
Hennissen, Leonie
Bakker, Mireille
Buitelaar, Jan K.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 : S50 - S50
[9] Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials
Holmskov, Mathilde
Storebo, Ole Jakob
Moreira-Maia, Carlos R.
Ramstad, Erica
Magnusson, Frederik Logstrup
Krogh, Helle B.
Groth, Camilla
Gillies, Donna
Zwi, Morris
Skoog, Maria
Gluud, Christian
Simonsen, Erik
PLOS ONE, 2017, 12 (06):
[10] Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion
Stuhec, Matej
Munda, Barbara
Svab, Vesna
Locatelli, Igor
JOURNAL OF AFFECTIVE DISORDERS, 2015, 178 : 149 - 159

← 1 2 3 4 5 →